ENTITY
Illumina Inc

Illumina Inc (ILMN US)

91
Analysis
Health Care • United States
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
more
bullish•GRAIL
•21 Feb 2025 22:39

GRAIL’s 4Q’FY24 Financial Results: The Company Is On Track To Complete FDA/PMA Submission In FY26

In my insight, I discuss GRAIL’s 4Q’FY24 financial results, outline key revenue growth drivers and update my financial model.

Share
bullish•Illumina Inc
•17 Feb 2025 15:00

Illumina Inc.: Is its Transition to NovaSeq X Series Noteworthy?

Illumina, a leading genomic sequencing company, reported its financial results for the fourth quarter of 2024, marking a slight revenue increase...

Logo
477 Views
Share
bullish•AppLovin
•24 Dec 2024 21:27

S&P500 December 2024 Forecast (Final): Flipping the COIN

Lennox International (LII US) - the top migration candidate - was announced as an addition to the S&P 500 on 18 December, soon after the quarterly...

Share
•05 Dec 2024 18:16

Quiddity Leaderboard S&P 500 Dec 24 Rebal - Final Predictions

The S&P500/400/600 rebal data "fixed" on 4 Dec open. The announcement will be made post-close 6 Dec. Applovin is up 900% in a year and is a top...

Logo
1.5k Views
Share
bullish•AppLovin
•22 Nov 2024 13:59

S&P500 December 2024 Forecasts: APP, APO and TPL Leading the Pack

Texas Pacific Land (TPL) - the top migration candidate - has been announced as an addition to S&P500 prior to the quarterly review as it is...

Share
x